首页 >> 学科动态 >> 学术前沿 >> 正文
 
从TNT的结果看:LDL应该降低到什么水平?


TNT(Treating to New Targets)研究结果最近在ACC2005年会上报告。它反映降LDL越积极,病人的预后越好。对大多数医生来说,不感意外。以前已有多项研究提示这一认识。例如PROVE-IT反映80mg Atorvastatin用于ACS病人,优于40mg Pravastatin;REVERSAL比较此两种药物,反映Atorvastatin遏制动脉粥样硬化进程更有效(Cannon CP. Braunwald E etal. Intensive versus Moderate lowering Lipid-Lowering with statin after ACS. NEJM 2004; 350: 1495; Nissan SE etal. Effect of intensive versus moderate lipid-lowering therapy on progression of coronary atheroscherosis, randomized controlled trial JAMA 2004; 291: 1071)。此外,HPS和ASCOT-LLA表明,无论病人基础胆固醇水平高、低,均获益于他汀治疗(MRC/BHF Heart Protection Study of Cholesterol lowering with simvastatin in 25,536 high risk individual. a randomized placebo controlled trial .Lancet 2002; 360: 7; Socer PS etal. Prevention of coronary and cardiova
您正在浏览的网页是文摘

点这里查看全文

编辑推荐
推广